Trading of Zogenix Common Stock Halted
December 07, 2012 07:01 ET
|
Zogenix
FDA Advisory Committee Reviewing Zohydro™ ER New Drug Application
Zogenix to Host Conference Call at 6:30 pm ET Today
SAN DIEGO, Dec. 7, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc....
Zogenix Appoints New Chief Commercial Officer
November 26, 2012 07:30 ET
|
Zogenix
SAN DIEGO, Nov. 26, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix to Present at the 24th Annual Piper Jaffray Healthcare Conference
November 15, 2012 08:00 ET
|
Zogenix
SAN DIEGO, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection
November 13, 2012 07:00 ET
|
Zogenix
COLUMBUS, Ohio and SAN DIEGO, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Battelle, the world's largest independent research and development organization and Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical...
Zogenix Reports Third Quarter 2012 Financial Results
November 08, 2012 16:01 ET
|
Zogenix
Growth Continues in Product Sales and Pipeline Remains on Track
Conference Call and Webcast Today, November 8th, at 4:30 p.m. ET
SUMAVEL® DosePro® (sumatriptan injection) Third...
Zogenix Announces FDA Advisory Committee Review of Zohydro(TM) ER for the Management of Chronic Pain
November 08, 2012 09:25 ET
|
Zogenix
SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
October 25, 2012 08:00 ET
|
Zogenix
SAN DIEGO, Oct. 25, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix to Present New Case Study Highlighting Successful Repositioning of Injectable Sumatriptan for Migraine With a Novel Needle-Free Delivery Technology
October 23, 2012 08:01 ET
|
Zogenix
SAN DIEGO, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix Announces Availability of New Resources for Migraine Sufferers at www.SUMAVELDosePro.com to Support National Pain Awareness Month
September 27, 2012 08:00 ET
|
Zogenix
SAN DIEGO, Sept. 27, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...
Zogenix to Present at Stifel Nicolaus 2012 Healthcare Conference
August 30, 2012 16:30 ET
|
Zogenix
SAN DIEGO, Aug. 30, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and...